William Blair
http://www.williamblair.comWilliam Blair & Company, L.L.C. is a Chicago-based investment firm offering investment banking, asset management, equity research, institutional and private brokerage, and private capital to individual, institutional, and issuing clients. Since 1935, it has been committed to helping clients achieve their financial objectives.
-
Axsome Therapeutics (AXSM) Prices 3M Share Offering at $75/sh
-
Axsome Therapeutics Announces Pricing of Public Offering of $225 Million of Shares of Common Stock
-
Axsome Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Update
-
Axsome Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Update
-
Axsome Therapeutics to Present at Upcoming Investor Conferences
-
Axsome Therapeutics to Present at Upcoming Investor Conferences
-
Axsome Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update
-
Axsome Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update
-
Axsome Therapeutics (AXSM) Highlighted as Takeover Target by Analyst
-
William Blair Reiterates Outperform Rating on Axsome Therapeutics (AXSM); Top Pick and on Take-Out Watch List
-
Axsome Therapeutics Announces Closing of $200 Million Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Axsome Therapeutics Announces Closing of $200 Million Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Axsome Therapeutics (AXSM) Prices 2M Share Offering at $87
-
Axsome Therapeutics Announces Pricing of Public Offering of $174 Million of Shares of Common Stock
-
Axsome Therapeutics Announces Pricing of Public Offering of $174 Million of Shares of Common Stock
-
William Blair Starts Axsome Therapeutics (AXSM) at Outperform
